EUVIMEDEUVIMED entdecken
Crossref

Ultrastable PLGA-Coated 177 Lu-Microspheres for Radioembolization Therapy of Hepatocellular Carcinoma

Shuo Jin, Jintao Huang, Yi Dong, Di Hu, Jing Sun, Zhihao Li, Bin-Yan Zhong, Zhiyong Liu, Ran Zhu iD, Guanglin Wang iD

Molecular Pharmaceutics · 2024

DOI: 10.1021/acs.molpharmaceut.4c00138 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2024. Verfasst von Shuo Jin und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection, Collaborative Innovation Center of Radiation …. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Polylactic Acid-Polyglycolic Acid Copolymer, Microspheres. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Priority Academic Program Development of Jiangsu Higher Education Institutions, Interdisciplinary Basic Frontier Innovation Program of Suzhou Medical College of Soochow University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Transarterial radioembolization (TARE) is a highly effective localized radionuclide therapy that has been successfully used to treat hepatocellular carcinoma (HCC). Extensive research has been conducted on the use of radioactive microspheres (MSs) in TARE, and the development of ideal radioactive MSs is crucial for clinical trials and patient treatment. This study presents the development of a radioactive MS for TARE of HCC. These MSs, referred to as 177Lu-MS@PLGA, consist of poly(lactic-co-glycolic acid) (PLGA) copolymer and radioactive silica MSs, labeled with 177Lu and then coated with PLGA. It has an extremely high level of radiostability. Cellular experiments have shown that it can cause DNA double-strand breaks, leading to cell death. In vivo radiostability of 177Lu-MS@PLGA is demonstrated by microSPECT/CT imaging. In addition, the antitumor study has shown that TARE of 177Lu-MS@PLGA can effectively restrain tumor growth without harmful side effects. Thus, 177Lu-MS@PLGA exhibits significant potential as a radioactive MS for the treatment of HCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsPolylactic Acid-Polyglycolic Acid CopolymerMicrospheresLutetiumRadioisotopesEmbolization, TherapeuticAnimalsHumansMiceCell Line, TumorMice, Inbred BALB CMice, NudeRadiopharmaceuticalsXenograft Model Antitumor Assays

Stichwörter der Autor:innen

177Luhepatocellular carcinomaradioactive microspheresradiostabilitytransarterial radioembolization

Substanzen

Polylactic Acid-Polyglycolic Acid CopolymerLutetiumRadioisotopesLutetium-177Radiopharmaceuticals

Autor:innen und Institutionen

  • State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection, Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions, Soochow University,…
  • Department of Interventional Radiology, the First Affiliated Hospital of Soochow University, Suzhou 215006, China.

ORCID-Profile: Ran Zhu, Guanglin Wang

Förderung

  • National Natural Science Foundation of China
  • Priority Academic Program Development of Jiangsu Higher Education Institutions
  • Interdisciplinary Basic Frontier Innovation Program of Suzhou Medical College of Soochow University

Zitieren

APA

Jin, S., Huang, J., Dong, Y., Hu, D., Sun, J., Li, Z., Zhong, B. Y., Liu, Z., Zhu, R., & Wang, G. (2024). Ultrastable PLGA-Coated 177 Lu-Microspheres for Radioembolization Therapy of Hepatocellular Carcinoma. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.4c00138

Vancouver

Jin S, Huang J, Dong Y, Hu D, Sun J, Li Z, et al. Ultrastable PLGA-Coated 177 Lu-Microspheres for Radioembolization Therapy of Hepatocellular Carcinoma. Molecular Pharmaceutics. 2024. doi:10.1021/acs.molpharmaceut.4c00138

BibTeX
@article{Jin2024,
  author = {Jin, Shuo and Huang, Jintao and Dong, Yi and Hu, Di and Sun, Jing and Li, Zhihao and Zhong, Bin-Yan and Liu, Zhiyong and Zhu, Ran and Wang, Guanglin},
  title = {Ultrastable PLGA-Coated 177 Lu-Microspheres for Radioembolization Therapy of Hepatocellular Carcinoma},
  journal = {Molecular Pharmaceutics},
  year = {2024},
  doi = {10.1021/acs.molpharmaceut.4c00138}
}
Kostenlos starten →